A cross-sectional study of IGF-I determinants in women

Evidence is accumulating that elevated circulating insulin-like growth factor I (IGF-I) is related to increased cancer risk. The identification of hormonal, reproductive and lifestyle characteristics influencing its synthesis and bioavailability is of particular interest. Data from 400 women, who served as controls in two case–control studies nested within the same prospective cohort study, were combined. IGF-I, IGF-binding proteins 1, 2 and 3 (IGFBP-1, -2, -3) and insulin were measured in serum samples from all subjects and cotinine in 186 samples. Age appears to be the most important determinant of total IGF-I levels in women. Anthropometric measures, such as body mass index (BMI) or waist-to-hip ratio (WHR) do not seem to influence total IGF-I concentrations in peripheral blood, but may modulate IGF-I bioavailability through insulin-dependent changes in IGFBP-1 and -2 concentrations. Age at menarche, phase of the menstrual cycle at blood draw, parity, menopause, past oral contraceptive or hormone replacement therapy use, and tobacco smoking do not appear to exert an independent effect on IGF-I and its binding proteins. There was some suggestion that regular physical activity may increase total IGF-I and that women with positive family history of breast cancer might have higher IGF-I levels than those without such diagnosis in their relatives.

[1]  E. Riboli,et al.  A prospective study of insulin‐like growth factor‐I, IGF‐binding proteins‐1, ‐2 and ‐3 and lung cancer risk in women , 2001, International journal of cancer.

[2]  R. Kaaks,et al.  Energy balance and cancer: the role of insulin and insulin-like growth factor-I , 2001, The Proceedings of the Nutrition Society.

[3]  E. Riboli,et al.  Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. , 2000, Journal of the National Cancer Institute.

[4]  R. Shore,et al.  Serum insulin‐like growth factor‐I and breast cancer , 2000, International journal of cancer.

[5]  E. Riboli,et al.  Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. , 2000, Journal of the National Cancer Institute.

[6]  T. Rohan,et al.  Role of the insulin-like growth factor family in cancer development and progression. , 2000, Journal of the National Cancer Institute.

[7]  A. Renehan,et al.  Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3 , 1999 .

[8]  M. Bonnefoy,et al.  Influence of acute and chronic exercise on insulin-like growth factor-I in healthy active elderly men and women , 1999, Aging.

[9]  J. Veldhuis,et al.  Effects of gender on exercise-induced growth hormone release. , 1999, Journal of applied physiology.

[10]  R. Casamitjana,et al.  The role of IGF binding protein-3 as a parameter of activity in acromegalic patients. , 1999, European journal of endocrinology.

[11]  J. Christie,et al.  Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. , 1999, Journal of applied physiology.

[12]  C. Mantzoros,et al.  Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  M. Spitz,et al.  Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. , 1999, Journal of the National Cancer Institute.

[14]  B. Eliasson,et al.  Insulin Resistance in Smokers and Other Long-Term Users of Nicotine , 1999 .

[15]  Stampfer,et al.  Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. , 1999, Journal of the National Cancer Institute.

[16]  C. Mantzoros,et al.  Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. , 1998, Epidemiology.

[17]  M. Stampfer,et al.  Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. , 1998, Science.

[18]  David J Hunter,et al.  Circulating concentrations of insulin-like growth factor I and risk of breast cancer , 1998, The Lancet.

[19]  Pols,et al.  Serum free IGF‐I, total IGF‐I, IGFBP‐1 and IGFBP‐3 levels in an elderly population: relation to age and sex steroid levels , 1998, Clinical endocrinology.

[20]  D. Grobbee,et al.  Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[21]  N. Skakkebaek,et al.  Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle. , 1997, Human reproduction.

[22]  E. Barrett-Connor,et al.  Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. , 1997, American journal of epidemiology.

[23]  P. Cohen,et al.  Insulin-like Growth Factor (IGF)-binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-β1 on Programmed Cell Death through a p53- and IGF-independent Mechanism* , 1997, The Journal of Biological Chemistry.

[24]  C. Benbassat,et al.  Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures. , 1997, The Journal of clinical endocrinology and metabolism.

[25]  M. Taskinen,et al.  Smoking cessation improves insulin sensitivity in healthy middle‐aged men , 1997, European Journal of Clinical Investigation.

[26]  M. Blankenstein,et al.  Plasma Insulin-Like Growth Factor-I and High Affinity Growth Hormone-Binding Protein Levels Increase After Two Weeks of Strenuous Physical Training , 1997, International journal of sports medicine.

[27]  N. Santoro,et al.  Relationships between insulin-like growth hormone factor-I and estradiol in reproductive aging. , 1997, Fertility and sterility.

[28]  D. Clemmons.  Insulin-like growth factor binding proteins and their role in controlling IGF actions. , 1997, Cytokine & growth factor reviews.

[29]  B. Karlberg,et al.  Population-based reference values for IGF-I and IGF-binding protein-1: relations with metabolic and anthropometric variables. , 1997, European journal of endocrinology.

[30]  D. Kiel,et al.  Association of Insulin‐Like Growth Factor‐I with Body Composition, Weight History, and Past Health Behaviors in the Very Old: The Framingham Heart Study , 1997, Journal of the American Geriatrics Society.

[31]  E. Barrett-Connor,et al.  Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: the Rancho Bernardo Study. , 1996, The Journal of clinical endocrinology and metabolism.

[32]  Z. Gucev,et al.  Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. , 1996, The international journal of biochemistry & cell biology.

[33]  L. Giudice,et al.  Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle. , 1996, The Journal of clinical endocrinology and metabolism.

[34]  D. Schoenfeld,et al.  Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.

[35]  M. Thorén,et al.  Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. , 1995, The Journal of clinical endocrinology and metabolism.

[36]  Hongshun Wang,et al.  Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein-1 and -3 in women with regular menstrual cycles. , 1995, Fertility and sterility.

[37]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[38]  P. Jakeman,et al.  Changes in circulating insulin-like growth factor-binding protein-1 (IGFBP-1) during prolonged exercise: effect of carbohydrate feeding. , 1994, The Journal of clinical endocrinology and metabolism.

[39]  M. Taskinen,et al.  The insulin resistance syndrome in smokers is related to smoking habits. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[40]  B. Bengtsson,et al.  Serum insulin‐like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin , 1994, Clinical endocrinology.

[41]  N. Skakkebaek,et al.  The ratio between serum levels of insulin‐like growth factor (IGF)‐I and the IGF binding proteins (IGFBP‐1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients , 1994, Clinical endocrinology.

[42]  J. Ketelslegers,et al.  Nutritional regulation of the insulin-like growth factors. , 1994, Endocrine reviews.

[43]  A. Grossman,et al.  IGFBP‐1: A Metabolic Signal Associated With Exercise‐Induced Amenorrhoea , 1994, Neuroendocrinology.

[44]  U. Stenman,et al.  Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. , 1993, The Journal of clinical endocrinology and metabolism.

[45]  M. Ranke,et al.  Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. , 1993, The Journal of clinical endocrinology and metabolism.

[46]  U. Smith,et al.  Smoking induces insulin resistance—a potential link with the insulin resistance syndrome , 1993, Journal of internal medicine.

[47]  J. Bonneterre,et al.  Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. , 1993, European journal of cancer.

[48]  G. Reaven,et al.  Insulin resistance and cigarette smoking , 1992, The Lancet.

[49]  D. Clemmons,et al.  Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. , 1991, The Journal of clinical endocrinology and metabolism.

[50]  D. Clemmons,et al.  Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I. , 1991, Endocrinology.

[51]  T. Chard,et al.  Inter‐relations between growth hormone, insulin, insulin‐like growth factor‐l (IGF‐I), IGF‐binding protein‐1 (IGFBP‐1) and sex hormone‐binding globulin in acromegaly , 1991, Clinical endocrinology.

[52]  E. Poehlman,et al.  Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. , 1990, The Journal of clinical endocrinology and metabolism.

[53]  A. Rogol,et al.  Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. , 1987, The Journal of clinical endocrinology and metabolism.

[54]  R. Schimpff,et al.  Effect of the variations of female sex hormones during the menstrual cycle upon serum somatomedin and growth-promoting activity. , 1986, Hormone research.

[55]  M. Vance,et al.  Effects of human pancreatic growth hormone-releasing factor-40 on serum growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and somatomedin-C concentrations in normal women throughout the menstrual cycle. , 1984, The Journal of clinical endocrinology and metabolism.

[56]  N. Haley,et al.  Validation of self-reported smoking behavior: biochemical analyses of cotinine and thiocyanate. , 1983, American journal of public health.

[57]  R. Baxter,et al.  Regulation of hepatic growth hormone receptors by insulin. , 1978, Biochemical and biophysical research communications.

[58]  J. Buckler.  Exercise as a screening test for growth hormone release. , 1972, Acta endocrinologica.